-
Cyteir Therapeutics Secures $80 Million in Series C
Post on 2/11/21
-
Pulmatrix Announces $40 Million Registered Direct Offering
Post on 2/11/21
-
Signify Health Prices of IPO
Post on 2/11/21
-
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity
Post on 2/11/21
-
BIONIK Laboratories Reports Fiscal 2021 Q3 Financial Results
Post on 2/11/21
-
AlloVir Reports Full Year 2020 Financial Results
Post on 2/11/21
-
Genocea Provides Fourth Quarter 2020 Corporate Update
Post on 2/11/21
-
Acorda Therapeutics Sale of Manufacturing Operations to Catalent
Post on 2/11/21
-
Is Moderna Stock Overvalued?
Post on 2/11/21
-
Can KalVista Pharmaceuticals Stock Fly Higher?
Post on 2/11/21
-
Bioasis Announces Shares for Debt Transaction
Post on 2/10/21
-
Rhythm Pharmaceuticals Closes $172.5M Public Offering
Post on 2/10/21
-
Sensei Biotherapeutics Closes IPO
Post on 2/10/21
-
KalVista Pharmaceuticals Prices Upsized $193.5M Public Offering of Common Stock
Post on 2/10/21
-
Stealth BioTherapeutics Prices Of $4.7 Million Registered Direct Offering Of American Depositary Shares
Post on 2/10/21
-
Biogen Announces the Pricing Terms of its Cash Tender Offer
Post on 2/10/21
-
Entity Vor Biopharma Closes $200M IPO
Post on 2/10/21
-
2021's States with the Best & Worst Dental Health - WalletHub Study
Post on 2/10/21
-
Can COVID Vaccine Latecomer Ocugen Beat Pfizer and Moderna?
Post on 2/10/21
-
Why Collegium Pharmaceutical Rose Nearly 10% on Tuesday
Post on 2/10/21
-
Oncorus Proposes Public Offering of Common Stock
Post on 2/9/21
-
Vor Biopharma Closes Over $200M IPO
Post on 2/9/21
-
KalVista Pharmaceuticals Proposes Public Offering of Common Stock
Post on 2/9/21
-
Quanterix Closes Public Offering Including Exercise of Underwriters’ Option
Post on 2/8/21
-
Akebia Therapeutics to Report Fourth Quarter and Full-Year 2020 Financial Results
Post on 2/8/21
Boston
